Equity Overview
Price & Market Data
Price: $0.0₅1
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $1,275
Daily Volume: 0
Details
PsyBio Therapeutics Corp., a biotechnology company, engages in the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. PsyBio Therapeutics Corp. was formerly known as Leo Acquisitions Corp. and changed its name to PsyBio Therapeutics Corp. in January 2021. The company was incorporated in 2009 and is headquartered in Denver, Colorado.